Sam Yoon
Overview
Explore the profile of Sam Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang F, Sahu V, Peng K, Wang Y, Li T, Bala P, et al.
Gut
. 2024 Apr;
73(8):1280-1291.
PMID: 38621923
Objective: Genomic studies of gastric cancer have identified highly recurrent genomic alterations impacting RHO signalling, especially in the diffuse gastric cancer (DGC) histological subtype. Among these alterations are interchromosomal translations...
2.
Chung C, Trofimov A, Adams J, Kung J, Kirsch D, Yoon S, et al.
Sarcoma
. 2022 Mar;
2022:5540615.
PMID: 35345672
Background: External beam radiation therapy (RT) for retroperitoneal sarcoma often requires treatment of large target volumes close to critical normal tissues. Radiation may be limited by adjacent organs at risk...
3.
Chi P, Qin L, Nguyen B, Kelly C, DAngelo S, Dickson M, et al.
J Clin Oncol
. 2022 Jan;
40(9):997-1008.
PMID: 35041493
Purpose: Dual targeting of the gastrointestinal stromal tumor (GIST) lineage-specific master regulators, ETV1 and KIT, by MEK and KIT inhibitors were synergistic preclinically and may enhance clinical efficacy. This trial...
4.
Bartlett D, Howe J, Chang G, Crago A, Hogg M, Karakousis G, et al.
Ann Surg Oncol
. 2020 Apr;
27(6):1717-1720.
PMID: 32270420
No abstract available.
5.
Kelly C, Antonescu C, Bowler T, Munhoz R, Chi P, Dickson M, et al.
JAMA Oncol
. 2020 Jan;
6(3):402-408.
PMID: 31971541
Importance: Patients with advanced sarcoma have limited treatment options. Talimogene laherparepvec (T-VEC) has been shown to increase tumor-specific immune activation via augmenting antigen presentation and T-cell priming. Objective: To examine...
6.
Hedgire S, Elmi A, Kambadakone A, Yoon S, Blake M, Harisinghani M
Clin Imaging
. 2014 Feb;
38(3):279-82.
PMID: 24556330
The purpose of this study was to assess the attenuation characteristics of the Alloderm Biologic Mesh Spacer (ABMS) in the abdomen and pelvis. Of nine patients with ABMS, five underwent...
7.
Tejwani A, Kobayashi W, Chen Y, Rosenberg A, Yoon S, Raskin K, et al.
Cancer
. 2010 Aug;
116(24):5733-9.
PMID: 20737559
Background: Acral myxoinflammatory fibroblastic sarcoma (AMFS) is a rare, low-grade sarcoma that commonly affects the distal extremities. From the published cases, therapy for AMFS to date has been comprised of...
8.
Schwab J, Antonescu C, Boland P, Healey J, Rosenberg A, Nielsen P, et al.
Anticancer Res
. 2009 Jun;
29(6):1867-71.
PMID: 19528441
Background: Chordomas are rare tumors of the axial skeleton for which surgical resection remains the most reliable means of cure. PI-103 is a inhibitor of PI3K/AKT and mTOR activation. This...
9.
Laskey W, Yoon S, Calzada N, Ricciardi M
Catheter Cardiovasc Interv
. 2008 Jun;
72(2):212-20.
PMID: 18546233
Objective: To assess the effect of ischemic postconditioning on indices of coronary microvascular function during percutaneous coronary intervention (PCI) for acute ST segment elevation myocardial infarction (STEMI). Background: Myocardial tissue...
10.
Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, et al.
JAMA
. 2007 Jun;
297(21):2360-72.
PMID: 17545690
Context: Hereditary diffuse gastric cancer is caused by germline mutations in the epithelial cadherin (CDH1) gene and is characterized by an increased risk for diffuse gastric cancer and lobular breast...